ZILLOW GROUP INC - C (Z)

US98954M2008 - Common Stock

41.65  -1.47 (-3.41%)

After market: 41.55 -0.1 (-0.24%)

Fundamental Rating

4

Overall Z gets a fundamental rating of 4 out of 10. We evaluated Z against 66 industry peers in the Real Estate Management & Development industry. Z has a great financial health rating, but its profitability evaluates not so good. Z has a correct valuation and a medium growth rate.



2

1. Profitability

1.1 Basic Checks

Z had positive earnings in the past year.
In the past year Z had a positive cash flow from operations.
In the past 5 years Z always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: Z reported negative operating cash flow in multiple years.

1.2 Ratios

Z's Return On Assets of -2.33% is in line compared to the rest of the industry. Z outperforms 53.85% of its industry peers.
Z has a Return On Equity (-3.41%) which is in line with its industry peers.
Industry RankSector Rank
ROA -2.33%
ROE -3.41%
ROIC N/A
ROA(3y)-2.95%
ROA(5y)-3.2%
ROE(3y)-5.21%
ROE(5y)-5.59%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Z has a better Gross Margin (77.46%) than 89.23% of its industry peers.
Z's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.23%
GM growth 5Y-2.4%

7

2. Health

2.1 Basic Checks

Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, Z has less shares outstanding
Compared to 5 years ago, Z has more shares outstanding
The debt/assets ratio for Z has been reduced compared to a year ago.

2.2 Solvency

Z has an Altman-Z score of 3.05. This indicates that Z is financially healthy and has little risk of bankruptcy at the moment.
Z's Altman-Z score of 3.05 is fine compared to the rest of the industry. Z outperforms 75.38% of its industry peers.
The Debt to FCF ratio of Z is 10.19, which is on the high side as it means it would take Z, 10.19 years of fcf income to pay off all of its debts.
Z has a better Debt to FCF ratio (10.19) than 67.69% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that Z is not too dependend on debt financing.
Z has a better Debt to Equity ratio (0.24) than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 10.19
Altman-Z 3.05
ROIC/WACCN/A
WACC8.04%

2.3 Liquidity

A Current Ratio of 3.32 indicates that Z has no problem at all paying its short term obligations.
Z's Current ratio of 3.32 is fine compared to the rest of the industry. Z outperforms 69.23% of its industry peers.
A Quick Ratio of 3.32 indicates that Z has no problem at all paying its short term obligations.
Z's Quick ratio of 3.32 is fine compared to the rest of the industry. Z outperforms 72.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 3.32

6

3. Growth

3.1 Past

Z shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.22%.
Z shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.63% yearly.
The Revenue has been growing slightly by 6.03% in the past year.
Z shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)-9.22%
EPS 3Y52.23%
EPS 5Y26.63%
EPS growth Q2Q2.86%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y-16.49%
Revenue growth 5Y7.84%
Revenue growth Q2Q12.79%

3.2 Future

Z is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.11% yearly.
Based on estimates for the next years, Z will show a quite strong growth in Revenue. The Revenue will grow by 11.83% on average per year.
EPS Next Y20.49%
EPS Next 2Y29.26%
EPS Next 3Y32.54%
EPS Next 5Y25.11%
Revenue Next Year13.28%
Revenue Next 2Y13.64%
Revenue Next 3Y13.75%
Revenue Next 5Y11.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

Z is valuated quite expensively with a Price/Earnings ratio of 32.54.
Compared to the rest of the industry, the Price/Earnings ratio of Z indicates a somewhat cheap valuation: Z is cheaper than 69.23% of the companies listed in the same industry.
Z is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 19.63, the valuation of Z can be described as rather expensive.
78.46% of the companies in the same industry are more expensive than Z, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.30. Z is around the same levels.
Industry RankSector Rank
PE 32.54
Fwd PE 19.63

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, Z is valued a bit cheaper than the industry average as 63.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 57.87
EV/EBITDA N/A

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
Z's earnings are expected to grow with 32.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.59
PEG (5Y)1.22
EPS Next 2Y29.26%
EPS Next 3Y32.54%

0

5. Dividend

5.1 Amount

Z does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZILLOW GROUP INC - C

NASDAQ:Z (5/8/2024, 6:27:46 PM)

After market: 41.55 -0.1 (-0.24%)

41.65

-1.47 (-3.41%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.84B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 32.54
Fwd PE 19.63
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.59
PEG (5Y)1.22
Profitability
Industry RankSector Rank
ROA -2.33%
ROE -3.41%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 77.46%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.32
Quick Ratio 3.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-9.22%
EPS 3Y52.23%
EPS 5Y
EPS growth Q2Q
EPS Next Y20.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.03%
Revenue growth 3Y-16.49%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y